Allied health professional treatments for chronic nonspecific low back pai

Not Applicable

Recruiting

• Conditions: Chronic nonspecific low back pain; Musculoskeletal - Other muscular and skeletal disorders

• Registration Number: ACTRN12618001298202
• Lead Sponsor: niversity of Newcastle

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2018-08-01
• Last Update Posted: 7 December 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Participants must have a history of chronic nonspecific low back pain (CNLBP) of three months or greater as confirmed by a general practitioner. The CNLBP will need to be located between the ribs and buttock creases to be eligible. Additionally, participants are required to be proficient in English and report a score of 3 or greater for their CNLBP on the Numeric Pain Rating Scale to ensure a minimally clinically important change for this score can be measured.

Exclusion Criteria

Participants will be excluded if they have non-mechanical low back pain (LBP) (e.g. spinal stenosis, spondylolisthesis, recent fractures, spinal surgery, tumours), specific LBP (e.g. herniated disc) acute or subacute LBP of any type, previous lower back surgery, neurological deficit, inflammatory joint disease, are pregnant or have previous (within the last 12 months) or current use of foot orthotic devices.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pain as assessed by a numeric pain rating scale. [Baseline, 12 weeks (primary time-point), 26 weeks, and 52 weeks after intervention commencement. ];Function as assessed by the Oswestry Disability Index. [Baseline, 12 weeks (primary time-point), 26 weeks and 52 weeks after intervention commencement. ]

Secondary Outcome Measures

Name	Time	Method
Physical activity level as assessed by the International Physical Activity Questionnaire (short-7).[Baseline, 12 weeks, 26 weeks, and 52 weeks after intervention commencement. ];Transversus abdominis muscle thickness as assessed by ultrasound. [Baseline and 12 weeks after intervention commencement. ];Gluteus medius muscle activity as assessed by electromyography. [Baseline and 12 weeks after intervention commencement. ];Number of hours foot orthotic worn as assessed by a self-reported diary provided at baseline.[12 weeks after intervention commencement.];Self reported adverse events associated with the intervention/s. Examples of known possible adverse events include: pain, discomfort, irritation, blister formation, and redness. [At any point from after intervention commencement to the end of the trial period (52 weeks).]